Sameep Kadakia1, Samuel N Helman2, Arvind K Badhey2, Masoud Saman3, Yadranko Ducic4. 1. Department of Otolaryngology/Head and Neck Surgery, New York Eye and Ear Infirmary, New York, NY, United States. Electronic address: skadakia@nyee.edu. 2. Albert Einstein College of Medicine, Bronx, NY, United States. 3. Department of Otolaryngology/Head and Neck Surgery, New York Eye and Ear Infirmary, New York, NY, United States. 4. Department of Facial Plastic and Reconstructive Surgery, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Abstract
OBJECTIVES: The molecular underpinnings of Treacher Collins Syndrome (TCS) are diverse. This article codifies the most recent findings in this complex area of research to further current understanding of the disease process. Elucidating the genetic causes of the disorder can be useful in earlier detection and better treatment planning. DESIGN: Articles from 1991 to 2013 were selected and reviewed by five researchers utilizing the most recent literature of the genetics and pathophysiology of TCS. RESULTS: Mutations in TCOF1, POLR1C and POLR1D have all been implicated in causing TCS. The association of the TCOF1 gene product, Treacle, and gene products of POLR1C and POLR1D with ribosome biosynthesis suggests that a loss of function mutation in these genes disrupts ribosome biosynthesis in constituent neural crest cells and neuroepithelium leading to apoptosis. However, recent data illustrating that P53 heterozygosity is protective against TCS, and that P53 and TCOF1 hemizygous embryos do not affect ribosomal function, implicates P53 or elements downstream of P53 as playing a role in TCS pathogenesis. CONCLUSION: Our study codified nascent findings of the molecular determinants of TCS. These findings add to a burgeoning database of TCS-associated mutations, and as such, can be used to establish TCS diagnosis and further clarify TCS pathogenesis.
OBJECTIVES: The molecular underpinnings of Treacher Collins Syndrome (TCS) are diverse. This article codifies the most recent findings in this complex area of research to further current understanding of the disease process. Elucidating the genetic causes of the disorder can be useful in earlier detection and better treatment planning. DESIGN: Articles from 1991 to 2013 were selected and reviewed by five researchers utilizing the most recent literature of the genetics and pathophysiology of TCS. RESULTS: Mutations in TCOF1, POLR1C and POLR1D have all been implicated in causing TCS. The association of the TCOF1 gene product, Treacle, and gene products of POLR1C and POLR1D with ribosome biosynthesis suggests that a loss of function mutation in these genes disrupts ribosome biosynthesis in constituent neural crest cells and neuroepithelium leading to apoptosis. However, recent data illustrating that P53 heterozygosity is protective against TCS, and that P53 and TCOF1 hemizygous embryos do not affect ribosomal function, implicates P53 or elements downstream of P53 as playing a role in TCS pathogenesis. CONCLUSION: Our study codified nascent findings of the molecular determinants of TCS. These findings add to a burgeoning database of TCS-associated mutations, and as such, can be used to establish TCS diagnosis and further clarify TCS pathogenesis.
Authors: Eliezer Calo; Bo Gu; Margot E Bowen; Fardin Aryan; Antoine Zalc; Jialiang Liang; Ryan A Flynn; Tomek Swigut; Howard Y Chang; Laura D Attardi; Joanna Wysocka Journal: Nature Date: 2018-01-24 Impact factor: 49.962